Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eileen Francis

Reporter

Washington, DC
Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.

Latest From Eileen Francis

GuruNanda’s ‘Reverse Cavities’ Claims On Coconut Oil Rinse Meet NAD SWIFT Review

Oral Essentials filed a Fast-Track SWIFT review case with the National Advertising Division against competitor GuruNanda LLC, whose endorsers claimed its pulling oil could reverse cavities. The marketer agreed to ensure that claims in question were discontinued.

Regulation Advertising, Marketing & Sales

Cosmetics Stakeholders Watching October For FDA Proposal On Allergen Labeling

Anna Benevente, director of the Product, Labeling and Ingredient Review Department at consultancy Registrar Corp, offers perspective on the US FDA’s overdue rulemaking proposal for fragrance allergen labeling on cosmetic products under MoCRA, as well as adverse event reporting compliance.

Regulation FDA

Kenvue Highlights Efficacy, Tolerability Of 0.1% Retinol As EU Prohibits Higher Concentrations

Kenvue is promoting results of the "largest-ever" assessment of retinol efficacy and tolerability in part to counter misleading information on the ingredient, which remains the “gold standard” for addressing signs of skin aging, it says.

Research & Development Market Intelligence

Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data

In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials. 

United States Beauty

PETA Challenges FDA 'Insistence' On Animal Testing For Sunscreen Products

Animal advocacy group PETA claims documents recently made public on listening sessions between the US Food and Drug Administration and sunscreen manufacturers show FDA is ‘checking a box by pushing decades-old animal tests rather than using modern science’ to assess the safety of sunscreens, despite the agency’s claims that it is encouraging non-animal methods.

FDA Animal Testing

L’Oreal Doubles Down On Biotech; LIFT Beauty Accelerator; EVER Skin Care Acquired; Cosmetics News

Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet,” says L’Oréal Groupe’s Guive Balooch on the firm’s expanded partnership with Debut Biotechnology. More cosmetics news in brief.

M & A Deals
See All
UsernamePublicRestriction

Register